Menlo Therapeutics Inc. Intellectual Property Contracts & Agreements
5 Contracts & Agreements
- License Agreements (5 contracts)
- License Agreement, dated as of April 28, 2023, by and between VYNE Therapeutics Inc. and Tay Therapeutics Limited (Filed With SEC on August 14, 2023)
- License Agreement (Topical), dated as of August 9, 2021, by and between In4Derm Limited and VYNE Therapeutics Inc (Filed With SEC on November 10, 2021)
- License Agreement, dated as of April 21, 2020, by and between Foamix Pharmaceuticals Ltd. and Cutia Therapeutics (HK) Limited (Filed With SEC on August 6, 2020)
- Exclusive License Agreement, dated as of December 20, 2012, by and between the Company and Merck Sharp & Dohme Corp (Filed With SEC on January 18, 2018)
- Exclusive License Agreement, dated as of December 20, 2012, by and between the Company and Merck Sharp & Dohme Corp (Filed With SEC on December 28, 2017)